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Abstract The differential display (DD) was employed to 
identify the gene(s) responsible for 1,10-phenanthroline (OP)-
induced apoptosis in murine tumor cells (Sun, V., Bian, .1., 
Wang, Y. and Jacobs, C. (1997) Oncogene 14, 385-393 [1]). An 
OP-inducible gene was isolated which encodes mouse glutathione 
synthetase (GSS). The GSS mRNA level began to increase 6 h 
post O P treatment and remained at a high level thereafter up to 
24 h tested. Induction of GSS was found not to be associated with 
p53 activation. No significant induction of DNA fragmentation 
was detected in two murine tumor lines upon GSS transfection. 
This is the first observation indicating that GSS is inducible 
rather specifically by a metal chelator and that induction of GSS, 
however, is not sufficient to induce apoptosis. It may merely 
reflect a cellular response to OP-induced redox disturbance. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
1,10-Phenanthroline (OP) is a typical metal chelating re-
agent. It chelates Fe(II) and prevents Fe(II)-mediated hydrox-
yl radical formation through the Fenton reaction [2,3]. By 
doing so, O P has been shown to prevent hydroxyl radical-
induced D N A damage in a number of cellular systems [4-6]. 
It has recently been shown in a cell-free system that O P can 
inactivate D N A binding activity of p53, a zinc containing 
transcription factor and tumor suppressor [7]. We have ex-
tended this in vitro observation to intact cells and found 
that in contrast to in vitro results, O P actually activated p53 
D N A binding and transactivation activity in two murine tu-
mor lines, harboring endogenous wild-type p53 [1]. Activation 
of p53 was found to contribute to, but not to be required for 
subsequent apoptotic cell death. In an at tempt to identify and 
characterize the critical genes responsible for OP-induced 
apoptosis, we employed the differential display technique 
and report here the cloning of an OP-inducible gene, which 
encodes glutathione synthetase (GSS), the enzyme involved in 
the last step of glutathione (GSH) synthesis [8]. 
2. Materials and methods 
2.1. Cell maintenance and drug treatment 
Mouse JB6 tumor line (L-RT101), an epidermal originated tumor 
line, was cultured in minimal essential medium with Earle's salts 
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containing Superoxide dismutase; DMSO, dimethyl sulfoxide 
(BRL) containing 5% fetal calf serum (Sigma). The cell doubling 
time is about 16 h. H-Tx cells, a spontaneously transformed mouse 
liver line, were cultured in Dulbecco's modified Eagle medium con-
taining 10% fetal calf serum and 1 mM sodium pyruvate. The dou-
bling time is about 10 h for this line. Both cell lines harbor the wild-
type p53 as assayed by DNA sequencing [9,10]. Subconfluent cells 
were exposed to DMSO vehicle control, or OP (150 μΜ, Sigma) or 
other DNA damaging reagents, camptothecin (10 μΜ, Sigma), etopo-
side (10 μΜ, Sigma), or adriamycin (10 μΜ, Sigma) for various peri-
ods of time up to 24 h and subjected to the differential display and/or 
Northern analysis. All compounds were dissolved in DMSO. 
2.2. The differential display 
L-RT101 cells were treated with 150 μΜ OP (Sigma) for 6 h and 
subjected to the differential display analysis, using DMSO-treated 
cells as controls. The analysis was performed using an RNAimage 
kit B (GeneHunter), according to the manufacturer's instruction 
with a slight modification [11]. Briefly, total RNA was isolated using 
RNAzol solution (Tel-Test) and subjected to reverse transcription 
(RT), followed by polymerase chain reaction (PCR). The downstream 
primers are poly dT (Tl 1) with one nucleotide (G, A, or C) anchored 
at its 3' end and a Hindlll site at its 5' end (used for both RT and 
PCR) and the upstream primers are a 13 mer (H-AP 9 to H-AP16 for 
PCR only), consisting of a Hindlll site at its 5' end and a random-
made 7 nucleotides. The sets of primers which detected differential 
expression between the control and OP-treated cells were used again 
in another freshly prepared RNA to confirm the reproducibility. The 
fragments reproducibly showing differential expression were PCR am-
plified and used as probes for Northern analysis [12] of both L-RT101 
and H-Tx cells treated with OP. The clones detecting differential ex-
pression by Northern analysis were then subcloned into TA cloning 
vector (Invitrogen) and sequenced by DNA sequenase version 2.0 
(Amersham). The computer analysis was performed using the GCG 
program. 
2.3. GSS cloning and expression vector construction 
RT-PCR [9] was performed to clone the mouse GSS cDNA flank-
ing the entire coding region [13]. The primers used are GSHS.01 5' 
GGAATTCATGGCTACCAGCTGGGG and GSHS.02 5' 
GGAATTCAC ACAGGGTAGGGGTT. The resulting 1.4 kb frag-
ment was EcoRI digested and subcloned into a pre-digested eukary-
otic expression vector, pcDNA3 (Invitrogen). Both sense and anti-
sense constructs were obtained and verified by DNA sequencing. 
2.4. Transient transfection and DNA fragmentation assay 
Five independent GSS expressing clones, along with the antisense 
construct and vector control, were transiently transfected into both L-
RT101 and H-Tx cells by calcium phosphate method in a 10 cm dish. 
The DNA fragmentation assay was performed 40 h post transfection 
as detailed previously [1]. 
3. Results and discussion 
3.1. Cloning of GSS as an OP-inducible gene by the differential 
display 
The differential display (DD) technique was employed in an 
at tempt to isolate genes responsible for or associated with OP-
induced apoptosis in two murine tumor lines. Since OP-in-
duced apoptosis occurs obviously at 12 h post exposure [1], 
we reasoned that gene(s) responsible for apoptosis induction 
should be up- or down-regulated prior to the appearance of 
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Fig. 1. Identification of an OP-inducible fragment in L-RT101 tumor cells by the differential display: total RNA was isolated from L-RT101 
murine epidermal tumor cells either treated for 6 h with DMSO or 1,10-phananthroline (OP, 150 μΜ, dissolved in DMSO), and subjected to 
the DD analysis as described in Section 2. The arrow points to a fragment which was reproducibly seen only in OP-treated cells (A). The frag-
ment was cut out, PCR-amplified with primers H-APll and TllC (see Fig. 2), and used as a probe for Northern analysis of both L-RT101 
and H-Tx cells (B). The fragment detected two transcripts with a size of 2.1 kb and 1.2 kb, respectively. The ribosomal 28S and 18S were 
shown on the bottom as loading controls. 
apoptosis. Six hours of OP treatment was, therefore, con-
ducted in one of these tumor lines, L-RT101, followed by 
the DD analysis. A total of 8 differential expressed fragments 
(4 for up-regulation and 4 for down-regulation) were identi-
fied between DMSO control and OP-treated cells after two 
independent DD analyses, using 8 upstream primers and 3 
downstream primers (Fig. 1A and data not shown). All 8 
fragments were PCR amplified and used as the probes for 
Northern analysis. Both OP-treated L-RT101 and H-Tx cells 
were examined. The gene(s) of interest will be those either 
being induced or repressed by OP in both cell lines since 
they both undergo apoptosis after exposure to OP. Only 1 
of the 8 fragments (the one shown in Fig. 1 A) detected differ-
ential expression by Northern analysis. It detected two tran-
scripts with the size of 1.2 kb and 2.1 kb, respectively. Both 
transcripts express at a very low basal level and are induced 
dramatically by the OP treatment (Fig. IB). As previously 
described [11], the DD was able to identify differentially ex-
pressed genes, but with a high false positive rate. 
This fragment was then subcloned into a TA cloning vector 
and 13 resulting clones were sequenced. They fell into two 
different DNA sequences. Two clones (C1.7 and C1.9), repre-
senting these two different individual clones, were used indi-
vidually as probes for Northern analysis and each of them 
detected only one transcript with a size of 1.2 kb (C1.9) and 
2.1 kb (C1.7), respectively (data not shown). The computer 
analysis using the GCG program revealed that C1.9 was a 
novel gene, while C1.7, with a size of 312 bp (Fig. 2, top 
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Fig. 2. Nucleotide sequence of clone 7 (A) and 98% DNA sequence 
identity of clone 7 with mouse glutathione synthetase (B): the frag-
ment detected by the DD as shown in Fig. 1 was subcloned and 13 
independent clones were sequenced. They fell into two independent 
DNA sequences. Shown is the DNA sequence of a representive 
clone 7 (A). The primers used for the DD-PCR cloning were under-
lined. The computer database analysis revealed that this fragment is 
part of the 3' end untranslated sequence of mouse GSS (B). 
panel), had 98% identity to the 3' untranslated region of a 
newly isolated cDNA encoding mouse glutathione synthetase 
[13] (Fig. 2, bottom panel). The result indicated that one of 
OP-inducible genes is the mouse GSS. 
3.2. OP, but not other DNA damagelapoptosis-inducing 
reagents induces mGSS 
We have shown that GSS is subjected to OP induction. We 
next conducted a time course study of the GSS induction. 
Both L-RT101 and H-Tx cells were treated with 150 μΜ 
OP for 1, 2, 6, 12, and 24 h, along with the DMSO control, 
and subjected to Northern analysis using C1.7 as the probe. As 
shown in Fig. 3 (top panel), induction of GSS occurs 6 h post 
treatment and induced level remains up to 24 h. The same 
result was seen when a cDNA encoding the entire coding 
region of mouse GSS (generated by RT-PCR, see below) 
was used as the probe (data not shown). The result indicates 
that OP induces expression of the mouse GSS gene prior to 
the appearance of obvious apoptosis (which requires 12 h 
treatment [1]) and maintains a high level during apoptotic 
cell death. 
OP is a redox sensitive reagent, it may disturb intracellular 
redox balance and trigger the cellular response, such as in-
duction of GSS, the enzyme catalyzing the synthesis of an 
important intracellular thiol, GSH. To test whether other re-
dox sensitive enzymes were also subjected to OP induction, we 
chose to examine possible induction by OP of manganese 
Superoxide dismutase (MnSOD). The MnSOD, a mitochon-
drial enzyme catalyzing the dismutation of Superoxide anión 
to form hydrogen peroxide and water, was previously found 
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to be inducible by OP in anaerobic Escherichia coli [14]. As 
shown in Fig. 3 (bottom panel), OP treatment did not, how-
ever, induce MnSOD expression up to 24 h, suggesting that 
induction of GSS expression is rather specific by OP. 
We have previously shown that OP activates p53 and this 
activation contributes to apoptosis [1]. To examine whether 
GSS induction by OP falls into the p53 signal pathway, we 
treated cells with adriamycin, a DNA damage reagent and 
free radical producer, camptothecin, a topoisomerase I inhib-
itor and etoposide, a topoisomerase II inhibitor. All of these 
drugs were p53 activators and apoptosis inducers in a number 
of cell models, including L-RT101 [1,15-17]. As shown in Fig. 
4, unlike OP, these drugs did not cause the induction of GSS. 
Instead, camptothecin or adriamycin treatment caused inhib-
ition of GSS expression in L-RT101, but not in H-Tx cells. 
The result suggests that GSS induction might not be associ-
ated with p53 activation and subsequent apoptosis. It further 
suggests that the induction of GSS by OP is rather specific. 
3.3. No induction of apoptosislDNA fragmentation by GSS 
transfection 
To examine the association of GSS induction and OP-in-
duced apoptosis, a cDNA fragment flanking the entire open 
reading frame of mouse GSS was generated by RT-PCR [9] 
and was constructed into a CMV driven eukaryotic vector, 
pcDNA3. Five individual GSS expressing clones, along with 
an antisense clone and vector control, were transiently tran-
fected into both L-RT101 and H-Tx cells. After 40 h of trans-
fection, morphological appearance of cell detachment and 
shrinkage, characteristic of apoptosis, was examined under a 
microscope and was not observed in L-RT101 cells, but was 
seen in all transfected H-Tx cells (data not shown). Both de-
tached and attached cells were harvested and subjected to 
DNA fragmentation assay. As shown in Fig. 5, transient 
transfection of mouse GSS did not induce apoptotic DNA 
fragmentation in L-RT101 cells. Calcium transfection, how-
ever, induces apoptosis in H-Tx cells, since all transfectants, 
including the vector control, undergo apoptotic death as 
shown both in morphology and DNA fragmentation. These 
results suggested that OP-induced GSS expression is not cas-
ually related to apoptosis induction. It is worth noting, how-
ever, that unlike OP treatment by which all cells were virtually 
exposed to the drug due to its cellular permeability, transient 
transfection only caused expression of the introduced gene in 
10% of the L-RT101 cells, as determined by ß-galactosidase 
staining [1]. The lack of apoptosis might be due to the poor 
transfection efficiency. Nevertheless, the fact that (a) DNA 
damaging/apoptosis-inducing reagents fail to induce GSS 
and (b) transient transfection of GSS fails to induce apoptosis 
strongly suggests that GSS is not a p53 downstream target 
gene to mediate apoptosis and that GSS expression alone is 
not sufficient to induce apoptosis. We, however, cannot rule 
out the possibility that GSS expression may be necessary for 
apoptosis. OP has been shown to induce expression of a num-
ber of genes including Waf-l, Mdml in p53 pathway [1], GSS 
and a novel gene mentioned in this report. Expression of 
many other genes, yet to be identified, may also be induced 
or repressed in the process of OP-induced apoptosis. Biolog-
ical consequence of apoptosis may result from interactions 
among many OP-inducible/repressible genes and the expres-
sion of any of the single genes may not be sufficient. In fact, 
transient transfection of Waf-l (a p53 downstream target gene 
Y. SunIFEBS Letters 408 (1997) 16-20 19 
Fig. 3. Time course of GSS induction by OP: total RNA was isolated from L-RT101 and H-Tx cells after exposure to OP (150 μΜ) for a var-
ious time period up to 24 h, as indicated, and subjected (15 μg) to Northern analysis using clone 7 (A) or MnSOD cDNA (B, see [23]) as 
probes. The ribosomal 28S and 18S were used for loading controls. 
Fig. 4. Lack of induction of GSS by DNA damaging/apoptosis-inducing reagents: total RNA was isolated from L-RT101 and H-Tx cells after 
6 h exposure to DMSO (Cont), camptothecin (Camp 10 μΜ), etoposide (Eto 10 μΜ), or adriamycin (Adr 10 μΜ), and subjected (15 μg) to 
Northern analysis using 1.4 kb GSS cDNA flanking the entire open reading frame as a probe. Again, the ribosomal 28S and 18S were used 
for loading controls. Lanes 1-4 were RT-101 cells, while lanes 5-8 were H-Tx cells. 
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Fig. 5. GSS transfection is not sumcient to induce apoptosis: subconfluent L-RT101 and H-Tx cells in a 10 cm dish were transiently transfected 
with 5 independent GSS expressing cDNA clones, along with the vector and antisense controls. Both attached and detached cells were har-
vested 40 h post transfection and subjected to DNA fragmentation assay as detailed (Fig. 1). Top panel: L-RT101 cells. Bottom panel: H-Tx 
cells. The molecular weight markers were loaded in the first lane of each gel. 
and inducible by OP, see [1]) did not induce apoptotic DNA 
fragmentation in L-RT101 cells (data not shown). 
GSS catalyzes the ATP-dependent synthesis of GSH from 
γ-L-glutamyl-L-cysteine and glycine [8]. Human disease with 
GSS deficiency has been described. The patients with this 
disorder have the symptoms of massive 5-oxoprolinurine, met-
abolic acidosis, hemolytic anemia and central nervous system 
damage leading to mental retardation [8]. The gene encoding 
GSS has recently been cloned from humans, mice and rats 
[13,18,19]. Mutation inactivation of GSS has recently been 
documented in 5-oxoprolinuria patients [20]. We report here 
for the first time, to our knowledge, that GSS is an inducible 
gene. It is induced rather specifically by OP, a metal chelating 
reagent. The biological consequence of OP-induced GSS ex-
pression is not clear at the present time and is a subject for 
future investigation. It is likely that OP, as a redox sensitive 
compound, changes intracellular redox status by its metal 
chelating activity. As a result, the level of intracellular thiol, 
such as GSH may decrease which could trigger a series of 
cellular responses including the induction of GSS. It is there-
fore of interest to examine the expression of other genes in-
volved in GSH metabolism after OP exposure. The examples 
include γ-glutamylcysteine synthetase and multidrug resist-
ance-associated protein (MRP), both are inducible by heavy 
metals and cytokines in a number of cell models [21,22]. In 
summary, we have shown that GSS is inducible by OP and 
this induction is not sufficient to cause apoptosis. The finding 
reported here may, however, serve as the first step in the 
development of specific GSS-inducing drug(s) for the treat-
ment of these human diseases caused by GSS deficiency. 
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